BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris

Completed · Phase 2

Conditions studied: Acne Vulgaris

In brief

The purpose of this study is to compare the safety and efficacy of formulation BLI1100 to its vehicle in the treatment of moderate-severe acne vulgaris.

Key facts

Study ID

NCT01241331

Run by

Braintree Laboratories

People needed

233

Starts

2010-11-01

Last updated by the study team

2012-10-01

Who can join

Age: 12 and older, up to 45. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Qualifying Investigator's Global Assessment severity score
• Qualifying number of non-inflammatory lesions
• Qualifying number of inflammatory lesions

You may not qualify if…

• Facial hair (beard), excessive scarring, sunburn or other disfigurement that may obscure the accurate assessment of acne grade
• Using medications that are reported to exacerbate acne
• Any clinically relevant finding at their baseline physical examination or dermatological medical history such as severe systemic diseases or diseases of the facial skin
• Have a known hypersensitivity or previous allergic reaction to any of the components
• Patients who have participated in an investigational clinical, surgical, drug, or device study within the past 30 days
• Patients who, in the opinion of the investigator, should not be included in the study for any reason, including inability to follow study procedures

Where it is running

• Center for Dermatology Clincal Research — Fremont, California, United States
• Dermatology Research Associates — Los Angeles, California, United States
• Dermatology Specialists — Oceanside, California, United States
• Horizons Clinical Research Center — Denver, Colorado, United States
• North Florida Dermatology Associates — Jacksonville, Florida, United States
• Ameriderm Research — Ormond Beach, Florida, United States
• Atlanta Dermatology, Vein and Research Center — Alpharetta, Georgia, United States
• Peachtree Dermatology Associates Research Center — Atlanta, Georgia, United States
• Northwest Clinical Trials — Nampa, Idaho, United States
• The Indiana Clinical Trials Center — Plainfield, Indiana, United States
• The South Bend Clinic — South Bend, Indiana, United States
• Minnesota Clinical Study Center — Fridley, Minnesota, United States
• Academic Dermatology Associates — Albuquerque, New Mexico, United States
• Clinical Partners — Johnston, Rhode Island, United States
• DiscoveResearch — Bryan, Texas, United States
• Progressive Clinical Research — San Antonio, Texas, United States
• Dermatology Research Center — Salt Lake City, Utah, United States
• The Education and Research Foundation — Lynchburg, Virginia, United States
• Virginia Clinical Research — Norfolk, Virginia, United States
• Premier Clinical Research — Spokane, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.